Universe Pharmaceuticals INC (UPC) Return on equity 2019–2025
Universe Pharmaceuticals INC (UPC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-6.5%FY2025 · since FY2019: 61.0% → -6.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -6.5% | +12.6 pp |
| FY2024 | -19.2% | +4.3 pp |
| FY2023 | -23.5% | -23.5 pp |
| FY2022 | 0.0% | -24.1 pp |
| FY2021 | 24.1% | -12.2 pp |
| FY2020 | 36.3% | -24.6 pp |
| FY2019 | 61.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice